FRANKFURT--The following is a summary of analysts' forecasts for UBS AG (UBS) second-quarter results, based on a poll of six analysts conducted by Dow Jones Newswires (figures in million francs, EPS, dividend and target price in franc, according to IFRS). Earnings figures are scheduled to be released July 29.

=== 
                                                  Net 
                  Total       Total           attrib. 
2nd Quarter    revenues  oper. exp.     EBT    profit    EPS 
AVERAGE           7,002       5,829   1,093       750   0.20 
Prev. Year        7,389       6,369   1,020       690   0.18 
+/- in %           -5.2        -8.5    +7.1      +8.7   +8.3 
 
MEDIAN            6,917       5,902   1,114       762   0.20 
Maximum           7,353       5,972   1,188       797   0.21 
Minimum           6,754       5,541     981       652   0.17 
Amount                5           4       6         6      4 
 
Credit Suisse     6,909          --     981       754   0.20 
Deutsche Bank     6,754       5,541   1,188       769   0.20 
Goldman Sachs     7,079       5,935   1,123       782     -- 
Helvea               --          --   1,104       746     -- 
Kepler Cheuvreux  6,917       5,869     996       652   0.17 
Morgan Stanley    7,353       5,972   1,163       797   0.21 
 
 
              Target price  Rating                  DPS 2014 
 
AVERAGE              20.02  positive 3    AVERAGE       0.63 
Prev. Quarter        20.40  neutral  2    Prev. Year    0.25 
+/- in %              -1.9  negative 0    +/- in %      +150 
 
MEDIAN               21.00                MEDIAN        0.65 
Maximum              23.00                Maximum       0.70 
Minimum              16.50                Minimum       0.50 
Amount                   5                Amount           4 
 
Credit Suisse        16.50  Neutral                     0.70 
Deutsche Bank        21.00  Buy                         0.50 
Helvea               21.10  Buy                           -- 
Kepler Cheuvreux     18.50  Hold                        0.60 
Morgan Stanley       23.00  Overweight                  0.70 
=== 

Year-earlier figures are as reported by the company.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more THC Farmaceuticals (PK) Charts.
THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more THC Farmaceuticals (PK) Charts.